215 related articles for article (PubMed ID: 36316327)
21. The impact of 27-hydroxycholesterol on endometrial cancer proliferation.
Gibson DA; Collins F; Cousins FL; Esnal Zufiaurre A; Saunders PTK
Endocr Relat Cancer; 2018 Apr; 25(4):381-391. PubMed ID: 29371332
[TBL] [Abstract][Full Text] [Related]
22. Mining for Oxysterols in
Meljon A; Crick PJ; Yutuc E; Yau JL; Seckl JR; Theofilopoulos S; Arenas E; Wang Y; Griffiths WJ
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 31013940
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) mice.
Hendrikx T; Jeurissen ML; Bieghs V; Walenbergh SM; van Gorp PJ; Verheyen F; Houben T; Guichot YD; Gijbels MJ; Leitersdorf E; Hofker MH; Lütjohann D; Shiri-Sverdlov R
J Hepatol; 2015 Feb; 62(2):430-6. PubMed ID: 25281859
[TBL] [Abstract][Full Text] [Related]
24. De novo synthesis of steroids and oxysterols in adipocytes.
Li J; Daly E; Campioli E; Wabitsch M; Papadopoulos V
J Biol Chem; 2014 Jan; 289(2):747-64. PubMed ID: 24280213
[TBL] [Abstract][Full Text] [Related]
25. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.
DuSell CD; Umetani M; Shaul PW; Mangelsdorf DJ; McDonnell DP
Mol Endocrinol; 2008 Jan; 22(1):65-77. PubMed ID: 17872378
[TBL] [Abstract][Full Text] [Related]
26. Effect of oxysterols on hematopoietic progenitor cells.
Gregorio-King CC; Collier FM; Bolton KA; Ferguson M; Hosking JB; Collier GR; Kirkland MA
Exp Hematol; 2002 Jul; 30(7):670-8. PubMed ID: 12135663
[TBL] [Abstract][Full Text] [Related]
27. Activation of STAT-3 signalling by RECK downregulation
Shen Z; Jiao K; Teng M; Li Z
Free Radic Res; 2020 Mar; 54(2-3):126-136. PubMed ID: 31933392
[TBL] [Abstract][Full Text] [Related]
28. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.
Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S
Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559
[TBL] [Abstract][Full Text] [Related]
29. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.
DuSell CD; Nelson ER; Wang X; Abdo J; Mödder UI; Umetani M; Gesty-Palmer D; Javitt NB; Khosla S; McDonnell DP
Endocrinology; 2010 Aug; 151(8):3675-85. PubMed ID: 20501668
[TBL] [Abstract][Full Text] [Related]
30. Involvement of 27-hydroxycholesterol on the progression of non-small cell lung cancer via the estrogen receptor.
Takada I; Miyazaki T; Goto Y; Kanzawa H; Matsubara T; Namikawa-Kanai H; Shigefuku S; Ono S; Nakajima E; Morishita Y; Honda A; Furukawa K; Ikeda N
Am J Cancer Res; 2022; 12(9):4241-4253. PubMed ID: 36225627
[TBL] [Abstract][Full Text] [Related]
31. The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells.
Zhu D; Shen Z; Liu J; Chen J; Liu Y; Hu C; Li Z; Li Y
Toxicol Lett; 2016 Dec; 264():79-86. PubMed ID: 27856279
[TBL] [Abstract][Full Text] [Related]
32. Origin of oxysterols in hepatic bile of patients with biliary infection.
Yoshida T; Matsuzaki Y; Haigh WG; Fukushima S; Ikezawa K; Tanaka N; Lee SP
Am J Gastroenterol; 2003 Oct; 98(10):2275-80. PubMed ID: 14572579
[TBL] [Abstract][Full Text] [Related]
33. 27-Hydroxycholesterol Promotes Adiposity and Mimics Adipogenic Diet-Induced Inflammatory Signaling.
Asghari A; Ishikawa T; Hiramitsu S; Lee WR; Umetani J; Bui L; Korach KS; Umetani M
Endocrinology; 2019 Oct; 160(10):2485-2494. PubMed ID: 31386147
[TBL] [Abstract][Full Text] [Related]
34. Esterification of side-chain oxysterols by lysosomal phospholipase A2.
Abe A; Hiraoka M; Matsuzawa F; Aikawa SI; Niimura Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158787. PubMed ID: 32777483
[TBL] [Abstract][Full Text] [Related]
35. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.
Umetani M; Domoto H; Gormley AK; Yuhanna IS; Cummins CL; Javitt NB; Korach KS; Shaul PW; Mangelsdorf DJ
Nat Med; 2007 Oct; 13(10):1185-92. PubMed ID: 17873880
[TBL] [Abstract][Full Text] [Related]
36. Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.
Xu Y; Hutchison SM; Hernández-Ledezma JJ; Bogan RL
Mol Hum Reprod; 2018 Jan; 24(1):2-13. PubMed ID: 29177442
[TBL] [Abstract][Full Text] [Related]
37. Our evolving understanding of how 27-hydroxycholesterol influences cancer.
Ma L; Cho W; Nelson ER
Biochem Pharmacol; 2022 Feb; 196():114621. PubMed ID: 34043965
[TBL] [Abstract][Full Text] [Related]
38. Novel pathways for elimination of cholesterol by extrahepatic formation of side-chain oxidized oxysterols.
Diczfalusy U; Lund E; Lütjohann D; Björkhem I
Scand J Clin Lab Invest Suppl; 1996; 226():9-17. PubMed ID: 8981665
[TBL] [Abstract][Full Text] [Related]
39. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol.
Li-Hawkins J; Lund EG; Bronson AD; Russell DW
J Biol Chem; 2000 Jun; 275(22):16543-9. PubMed ID: 10748047
[TBL] [Abstract][Full Text] [Related]
40. 27-Hydroxylation of oncosterone by CYP27A1 switches its activity from pro-tumor to anti-tumor.
Ayadi S; Friedrichs S; Soulès R; Pucheu L; Lütjohann D; Silvente-Poirot S; Poirot M; de Medina P
J Lipid Res; 2023 Dec; 64(12):100479. PubMed ID: 37981011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
